Table of Content


1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Overview of Lab Automation
3.2. Historical Evolution of Lab Automation
3.3. Stages of Lab Automation
3.4. Process of Lab Automation
3.5. Advantages of Lab Automation Over Manual Handling
3.6. Challenges associated with Lab Automation
3.7. Future Perspectives

4. MARKET LANDSCAPE
4.1. Lab Automation System Manufacturers: Overall Market Landscape
4.1.1. Analysis by Year of Establishment
4.1.2. Analysis by Company Size
4.1.3. Analysis by Location of Headquarters
4.1.4. Analysis by Company Size and Location of Headquarters
4.1.5. Analysis by Type of Lab Automation System(s)
4.1.6. Analysis by Type of Automated Liquid Handler(s)
4.1.7. Analysis by Type of Automated Microplate(s)
4.1.8. Analysis by Stage(s) of Automation
4.1.9. Analysis by Application Area(s)
4.1.10. Analysis by Type of Lab Automation System(s) and Application Area(s)
4.1.11. Analysis by End-user(s)
4.1.12. Analysis by Stage(s) of Automation and End-user(s)

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Assumptions and Key Parameters
5.2 Methodology
5.3. Competitiveness Analysis: Very Small Companies based in North America (Peer Group I)
5.4. Competitiveness Analysis: Small Companies based in North America (Peer Group II)
5.5 Competitiveness Analysis: Mid-sized Players based in North America (Peer Group III)
5.5. Competitiveness Analysis: Large Companies based in North America (Peer Group IV)
5.6. Competitiveness Analysis: Very Large Companies based in North America (Peer Group V)
5.7 Competitiveness Analysis: Very Small Companies based in Europe (Peer Group VI)
5.8 Competitiveness Analysis: Small Companies based in Europe (Peer Group VII)
5.9. Competitiveness Analysis: Mid-sized Companies based in Europe (Peer Group VII)
5.10. Competitiveness Analysis: Large Companies based in Europe (Peer Group IX)
5.11. Competitiveness Analysis: Very Large Companies based in Europe (Peer Group X)
5.12. Competitiveness Analysis: Very Small Companies based in Asia-Pacific and Rest of the World (Peer Group XI)
5.13. Competitiveness Analysis: Small Companies based in Asia-Pacific and Rest of the World (Peer Group XII)
5.14. Competitiveness Analysis: Mid-sized Companies based in Asia-Pacific and Rest of the World (Peer Group XIII)
5.15. Competitiveness Analysis: Large Companies based in Asia-Pacific and Rest of the World (Peer Group XIV)
5.16. Competitiveness Analysis: Very Large Companies based in Asia-Pacific and Rest of the World (Peer Group XV)

6. COMPANY PROFILES
6.1. Abbott
6.1.1. Company Overview
6.1.2. Financial Information
6.1.3. Lab Automation Product Portfolio
6.1.4. Recent Developments and Future Outlook
6.2. Anton Paar
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. Lab Automation Product Portfolio
6.2.4. Recent Developments and Future Outlook
6.3. BD
6.3.1. Company Overview
6.3.2. Financial Information
6.3.3. Lab Automation Product Portfolio
6.3.4. Recent Developments and Future Outlook
6.4. Beckman Coulter
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Lab Automation Product Portfolio
6.4.4. Recent Developments and Future Outlook
6.5. ERWEKA
6.5.1. Company Overview
6.5.2. Financial Information
6.5.3. Lab Automation Product Portfolio
6.5.4. Recent Developments and Future Outlook
6.6. Leuze
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Lab Automation Product Portfolio
6.6.4. Recent Developments and Future Outlook
6.7. Ortho Clinical Diagnostics
6.7.1. Company Overview
6.7.2. Financial Information
6.7.3. Lab Automation Product Portfolio
6.7.4. Recent Developments and Future Outlook
6.8. Pall Corporation
6.8.1. Company Overview
6.8.2. Financial Information
6.8.3. Lab Automation Product Portfolio
6.8.4. Recent Developments and Future Outlook
6.9. PerkinElmer
6.9.1. Company Overview
6.9.2. Financial Information
6.9.3. Lab Automation Product Portfolio
6.9.4. Recent Developments and Future Outlook
6.10. Roche Diagnostics
6.10.1. Company Overview
6.10.2. Financial Information
6.10.3. Lab Automation Product Portfolio
6.10.4. Recent Developments and Future Outlook
6.11. Siemens Healthineers
6.11.1. Company Overview
6.11.2. Financial Information
6.11.3. Lab Automation Product Portfolio
6.11.4. Recent Developments and Future Outlook
6.12. SYSTAG
6.12.1. Company Overview
6.12.2. Financial Information
6.12.3. Lab Automation Product Portfolio
6.12.4. Recent Developments and Future Outlook

7. CASE STUDY: LAB AUTOMATION SOFTWARE
7.1. Lab Automation Software Providers: Overall Market Landscape
7.1.1. Analysis by Year of Establishment
7.1.2. Analysis by Company Size
7.1.3. Analysis by Location of Headquarters
7.1.4. Analysis by Company Size and Location of Headquarters
7.1.5. Analysis by Type of Software
7.1.6. Analysis by Mode(s) of Deployment
7.1.7. Analysis by Type of Software and Mode(s) of Deployment
7.1.8. Analysis by End-user(s)
7.1.9. Analysis by Type of Software and End-user(s)

8. PARTNERSHIPS AND COLLABORATIONS
8.1. Partnership Models
8.2. Lab Automation: List of Partnerships and Collaborations
8.2.1. Analysis by Year of Partnership
8.2.2. Analysis by Type of Partnership
8.2.3. Analysis by Year and Type of Partnership
8.2.4. Analysis by Type of Partner
8.2.5. Analysis by Year of Partnership and Type of Partner
8.2.6. Analysis by Type of Partnership and Type of Partner
8.2.7. Analysis by Type of Automation Instrument(s)
8.2.8. Analysis by Type of Partnership and Automation Instrument(s)
8.2.9. Most Active Players: Analysis by Number of Partnerships
8.2.10. Analysis by Geography
8.2.10.1. Local and International Agreements
8.2.10.2. Intracontinental and Intercontinental Agreements

9. PATENT ANALYSIS
9.1. Methodology and Key Parameters
9.2. Lab Automation: List of Patents
9.3. Analysis by Patent Publication Year
9.4. Analysis by Publication Year and Type of Patent
9.5. Analysis by Application Year
9.6. Analysis by Patent Jurisdiction
9.7. Analysis by CPC Symbols
9.8. Analysis by Type of Applicant
9.9. Word Cloud: Emerging Focus Areas
9.10. Analysis by Patent Age
9.11. Leading Industry Players: Analysis by Number of Patents
9.12. Leading Non-Industry Players: Analysis by Number of Patents
9.13. Leading Individual Assignees: Analysis by Number of Patents
9.14. Patent Benchmarking: Analysis of Leading Industry Players by Patent Characterization (CPC Symbols)
9.15. Patent Valuation: Methodology and Key Parameters
9.15.1. Analysis by Relative Patent Valuation
10. MARKET FORECAST AND OPPORTUNITY ANALYSIS
10.1. Methodology and Key Assumptions
10.2. Global Lab Automation Market, 2023-2035
10.2.1. Lab Automation Market: Distribution by Stage of Automation, 2023 and 2035
10.2.1.1. Lab Automation Market for Pre-analytical Stage, 2023-2035
10.2.1.2. Lab Automation Market for Analytical Stage, 2023-2035
10.2.1.3. Lab Automation Market for Post-analytical Stage, 2023-2035
10.2.1.4. Lab Automation Market for Total Lab Automation, 2023-2035
10.2.2. Lab Automation Market: Distribution by Type of Instrument, 2023 and 2035
10.2.2.1. Lab Automation Market for Automated Liquid Handling Systems, 2023-2035
10.2.2.2. Lab Automation Market for Automated Microplate Readers, 2023-2035
10.2.2.3. Lab Automation Market for Automated Sampling Systems, 2023-2035
10.2.2.4. Lab Automation Market for Analyzers, 2023-2035
10.2.2.5. Lab Automation Market for Automated Storage and Retrieval Systems (ASRS), 2023-2035
10.2.2.6. Lab Automation Market for Other Instruments, 2023-2035
10.2.3. Lab Automation Market: Distribution by Application, 2023 and 2035
10.2.3.1. Lab Automation Market for Diagnostics, 2023-2035
10.2.3.2. Lab Automation Market for Genomic Solutions, 2023-2035
10.2.3.3. Lab Automation Market for Microbiology, 2023-2035
10.2.3.4. Lab Automation Market for Drug Discovery, 2023-2035
10.2.3.5. Lab Automation Market for Proteomic Solutions, 2023-2035
10.2.3.6. Lab Automation Market for Other Applications, 2023-2035
10.2.4. Lab Automation Market: Distribution by End-user, 2023 and 2035
10.2.4.1. Lab Automation Market for Research and Diagnostic Laboratories, 2023-2035
10.2.4.2. Lab Automation Market for Biotechnology and Pharmaceutical Industries, 2023-2035
10.2.4.3. Lab Automation Market for Other End-users, 2023-2035
10.2.5. Lab Automation Market: Distribution by Key Geographical Regions,2023 and 2035
10.2.5.1. Lab Automation Market in North America, 2023-2035
10.2.5.2. Lab Automation Market in Europe, 2023-2035
10.2.5.3. Lab Automation Market in Asia-Pacific, 2023-2035
10.2.5.4. Lab Automation Market in Middle East and North Africa, 2023-2035
10.2.5.5. Lab Automation Market in Latin America, 2023-2035

11. EXECUTIVE INSIGHTS
11.1. Chapter Overview
11.2. Africa Medical Supplies Platform
11.2.1. Company Overview
11.2.2. Interview Transcript: Abiodun Sina-Olulana (Production and Supply Management Lead)
11.3. A.S.T. Biomedical
11.3.1. Company Overview
11.3.2. Interview Transcript: Barcella Mauro (Chief Executive Officer)
11.4. Berthold Technologies
11.4.1. Company Overview
11.4.2. Interview Transcript: Anonymous
11.5. Efevre Tech
11.5.1. Company Overview
11.5.2. Interview Transcript: Dimitris Kyriakou (Project Manager and Business Development)
11.6. HSE
11.6.1. Company Overview
11.6.2. Interview Transcript: Patrick Widler (Chief Commercial Officer)
11.7. Inheco
11.7.1. Company Overview
11.7.2. Interview Transcript: Daniel von Sierakowski (Account Manager)
11.8. LabWare
11.8.1. Company Overview
11.8.2. Interview Transcript: Mayookh Sengupta (Sales Manager)
11.9. SciRobotics
11.9.1. Company Overview
11.9.2. Interview Transcript: Shai Kaplan (Co-Founder and Co-Chief Executive Officer)

12. APPENDIX I: TABULATED DATA

13. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS